Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_provenance.
- NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_assertion description "[Treatment of ovarian cancer HEY cells with 500 nM 5alpha-dihydrotestosterone (DHT), but not estradiol-17beta or progesterone, for 60 h down-regulated the expression of mRNA for TGF-beta receptors I and II (TbetaR-I and TbetaR-II), betaglycan, and endoglin but had no effect on TGF-beta1 mRNA levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_provenance.
- NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_assertion evidence source_evidence_literature NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_provenance.
- NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_assertion SIO_000772 10706107 NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_provenance.
- NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_assertion wasDerivedFrom befree-20140225 NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_provenance.
- NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_assertion wasGeneratedBy ECO_0000203 NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP580239.RA3104OdXS7qJIMzLPWNGg5IYFeOleykMvCfo2bpFJFeU130_provenance.